AarogyaAI enables precision medicine for anti-microbial resistance in infectious disease by unlocking the power of genomics and artificial intelligence. Tuberculosis is the most lethal infectious disease, globally. Drug-resistant TB and its delayed diagnosis, exacerbate the problem.

AarogyaAI’s drug susceptibility test ensures patients are prescribed the most effective drugs, 100X faster than the existing gold standard.

The company is backed by the largest genomics company in the world, Illumina Inc. as part of the Illumina Accelerator Program at San Francisco, USA. The Minister of Health, Govt. of India, Startup India, BIRAC amongst others in the Indian Ecosystem have recognized and awarded the innovation.

Praapti pitches AarogyaAI at our Investor Day.